✦ LIBER ✦

Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer

✍ Scribed by Juan Miguel Gil; Carlos Rubio-Terrés; Almudena del Castillo; Paloma González; Felisa Canorea

Book ID: 107596147
Publisher: Springer Milan
Year: 2006
Tongue: Spanish
Weight: 827 KB
Volume: 8
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-006-0180-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost utility analysis of early adjuvant

Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective

✍ Jonathan Karnon; Thomas Delea; Vicki Barghout 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 297 KB

Risk of early recurrence among postmenop

Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen

✍ Hagen Kennecke; Heather McArthur; Ivo A. Olivotto; Caroline Speers; Chris Bajdik 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)‐positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi

Clinical significance of progesterone re

Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen

✍ Yong Wha Moon; Seho Park; Joo Hyuk Sohn; Dae Ryong Kang; Ja Seung Koo; Hyung Seo 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 235 KB

Cost-effectiveness of letrozole versus t

Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective

✍ Thomas E. Delea; Khalid El-Ouagari; Jonathan Karnon; Oleg Sofrygin 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 301 KB

A study of the effects of the aromatase

A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer

✍ Fiona M. McCaig; Lorna Renshaw; Linda Williams; Oliver Young; Juliette Murray; E 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 286 KB

Comparison of anastrozole versus tamoxif

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative “Arimidex” compared to Tamoxifen (PROACT) trial

✍ Luigi Cataliotti; Aman U. Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract ## BACKGROUND The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women with large, operable (T2/3, N0‐2, M0), or potentially operable (T4b, N0‐2, M0) br